167 related articles for article (PubMed ID: 19818956)
1. Fast generation of dendritic cells.
Kvistborg P; Boegh M; Pedersen AW; Claesson MH; Zocca MB
Cell Immunol; 2009; 260(1):56-62. PubMed ID: 19818956
[TBL] [Abstract][Full Text] [Related]
2. Experimental production of clinical-grade dendritic cell vaccine for acute myeloid leukemia.
Tan YF; Sim GC; Habsah A; Leong CF; Cheong SK
Malays J Pathol; 2008 Dec; 30(2):73-9. PubMed ID: 19291915
[TBL] [Abstract][Full Text] [Related]
3. Enhanced T-cell activation and T-cell-dependent IL-2 production by CD83+, CD25high, CD43high human monocyte-derived dendritic cells.
Velten FW; Rambow F; Metharom P; Goerdt S
Mol Immunol; 2007 Mar; 44(7):1544-50. PubMed ID: 17023048
[TBL] [Abstract][Full Text] [Related]
4. Comparison of monocyte-derived dendritic cells from colorectal cancer patients, non-small-cell-lung-cancer patients and healthy donors.
Kvistborg P; Bechmann CM; Pedersen AW; Toh HC; Claesson MH; Zocca MB
Vaccine; 2009 Dec; 28(2):542-7. PubMed ID: 19837091
[TBL] [Abstract][Full Text] [Related]
5. Murine dendritic cells generated under serum-free conditions have a mature phenotype and efficiently induce primary immune responses.
Warncke M; Dodero A; Dierbach H; Follo M; Veelken H
J Immunol Methods; 2006 Mar; 310(1-2):1-11. PubMed ID: 16337648
[TBL] [Abstract][Full Text] [Related]
6. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.
Trepiakas R; Pedersen AE; Met O; Hansen MH; Berntsen A; Svane IM
Vaccine; 2008 Jun; 26(23):2824-32. PubMed ID: 18450338
[TBL] [Abstract][Full Text] [Related]
7. Modulation of dendritic cell phenotype and function in an in vitro model of the intestinal epithelium.
Butler M; Ng CY; van Heel DA; Lombardi G; Lechler R; Playford RJ; Ghosh S
Eur J Immunol; 2006 Apr; 36(4):864-74. PubMed ID: 16544275
[TBL] [Abstract][Full Text] [Related]
8. Direct contact of platelets and their released products exert different effects on human dendritic cell maturation.
Hamzeh-Cognasse H; Cognasse F; Palle S; Chavarin P; Olivier T; Delézay O; Pozzetto B; Garraud O
BMC Immunol; 2008 Sep; 9():54. PubMed ID: 18817542
[TBL] [Abstract][Full Text] [Related]
9. TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1-type response.
Sioud M; Fløisand Y
Eur J Immunol; 2007 Oct; 37(10):2834-46. PubMed ID: 17853407
[TBL] [Abstract][Full Text] [Related]
10. Murine bone marrow mesenchymal stem cells cause mature dendritic cells to promote T-cell tolerance.
Wang Q; Sun B; Wang D; Ji Y; Kong Q; Wang G; Wang J; Zhao W; Jin L; Li H
Scand J Immunol; 2008 Dec; 68(6):607-15. PubMed ID: 18959624
[TBL] [Abstract][Full Text] [Related]
11. Multicenter study on in vitro characterization of dendritic cells.
Eichler H; Nguyen XD; Roelen D; Celluzzi CM; McKenna D; Pamphilon D; Blair A; Read EJ; Takahashi TA; Szczepiorkowski ZM;
Cytotherapy; 2008; 10(1):21-9. PubMed ID: 18202971
[TBL] [Abstract][Full Text] [Related]
12. Day 3 Poly (I:C)-activated dendritic cells generated in CellGro for use in cancer immunotherapy trials are fully comparable to standard Day 5 DCs.
Truxova I; Pokorna K; Kloudova K; Partlova S; Spisek R; Fucikova J
Immunol Lett; 2014 Jul; 160(1):39-49. PubMed ID: 24726860
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell-based immunogens for B-cell chronic lymphocytic leukemia.
Allgeier T; Garhammer S; Nössner E; Wahl U; Kronenberger K; Dreyling M; Hallek M; Mocikat R
Cancer Lett; 2007 Jan; 245(1-2):275-83. PubMed ID: 16516377
[TBL] [Abstract][Full Text] [Related]
14. Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection.
Erdmann M; Dörrie J; Schaft N; Strasser E; Hendelmeier M; Kämpgen E; Schuler G; Schuler-Thurner B
J Immunother; 2007 Sep; 30(6):663-74. PubMed ID: 17667530
[TBL] [Abstract][Full Text] [Related]
15. Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I.
Liu Q; Zhang C; Sun A; Zheng Y; Wang L; Cao X
J Immunol; 2009 May; 182(10):6207-16. PubMed ID: 19414774
[TBL] [Abstract][Full Text] [Related]
16. A novel method for isolating dendritic cells from human bronchoalveolar lavage fluid.
Ten Berge B; Muskens F; Kleinjan A; Hammad H; Hoogsteden HC; Lambrecht BN; Van den Blink B
J Immunol Methods; 2009 Dec; 351(1-2):13-23. PubMed ID: 19804781
[TBL] [Abstract][Full Text] [Related]
17. Culture medium and protein supplementation in the generation and maturation of dendritic cells.
Royer PJ; Tanguy-Royer S; Ebstein F; Sapede C; Simon T; Barbieux I; Oger R; Gregoire M
Scand J Immunol; 2006 Jun; 63(6):401-9. PubMed ID: 16764693
[TBL] [Abstract][Full Text] [Related]
18. Cells with dendritic cell morphology and immunophenotype, binuclear morphology, and immunosuppressive function in dendritic cell cultures.
Dong R; Moulding D; Himoudi N; Adams S; Bouma G; Eddaoudi A; Basu BP; Derniame S; Chana P; Duncan A; Anderson J
Cell Immunol; 2011; 272(1):1-10. PubMed ID: 22030471
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin downregulates the inhibitory receptors ILT2, ILT3, ILT4 on human dendritic cells and yet induces T cell hyporesponsiveness independent of FoxP3 induction.
Fedoric B; Krishnan R
Immunol Lett; 2008 Oct; 120(1-2):49-56. PubMed ID: 18652845
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of human embryonic stem cells into immunostimulatory dendritic cells under feeder-free culture conditions.
Su Z; Frye C; Bae KM; Kelley V; Vieweg J
Clin Cancer Res; 2008 Oct; 14(19):6207-17. PubMed ID: 18829500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
